您好,欢迎来到皮书数据库!
热点推荐: 双循环
更多>> 课题组动态
更多>> 皮书作者
谢伏瞻
    中国社会科学院学部委员,学部主席团主席,研究员,博士生导师。历任中国社会科学院院长、党组书记,国务院发展中心副主... 详情>>
蔡 昉
    中国社会科学院国家高端智库首席专家,学部委员,学部主席团秘书长,研究员,博士生导师。先后毕业于中国人民大学、中国... 详情>>
李培林
    男,汉族,出生于1955年5月,山东济南人,博士,研究员,全国人民代表大会社会建设委员会副主任委员,中国社会科学... 详情>>

    2021~2022年中国健康险产品演进分析

    摘要

    2021年以来,商业健康险产品结构基本稳定,重疾险、医疗险、护理险的相对关系未出现大的改变。但不可忽视的是,重疾险的新单销售量相较之前大幅下降,新客户获取极为困难。惠民保延续着越发高涨的发展态势,而百万医疗保险进入了存量客户经营的阶段。先进医疗聚合产品因其包含的特药、特械、先进疗法等多种医疗资源表现出了旺盛的生命力。长期护理保险、慢病人群保险、老年人群保险、消费型医疗保险仍处于发展的起步阶段。

    <<
    >>

    Abstract

    Since 2021,the product structure of private health insurance has been stable,and the relative relationship among critical illness insurance,medical insurance,and nursing insurance has not changed significantly. However,new critical illness insurance sales have fallen sharply,making it extremely difficult to obtain new customers. Inclusive supplementary medical insurance continues to develop more and more rapidly,and million-medical insurance has entered the stage of customer management. Advanced medical aggregation products show great vitality because they include particular medicine,equipment,advanced therapy,and other medical resources. Long-term care insurance,chronic patient insurance,elderly insurance,and consumer health insurance are still in the initial stage of development.

    <<
    >>
    作者简介
    王明彦:
    丁莹:
    孙啸辰:
    陆静:
    郭炜钦:
    <<
    >>
    相关报告